
The program below may still be subject to further changes as arrangements with speakers are finalised.
THURSDAY - 23rd May 2019
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
08:30-8:40
Introduction and Acknowledgements
Associate Professor Antiopi Varelias
8:40-8:50
Welcome and Conference Objectives
Professor David Whiteman
08:50-09:00
Welcome to Brisbane
Hon Dr Steven Miles, the Minister for Health and Minister for Ambulance Services in the Palaszczuk Labor Government
Location: Boulevard Auditorium
Chair: Professor Ranjeny Thomas
Professor Marco Colonna, Department of Pathology and Immunology, Washington University, St. Louis
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Professor Ranjeny Thomas
10:30-11:00
Professor Qizhi Tang, Director, UCSF Transplantation Research Lab, Department of Surgery, University of California, San Francisco - Translating regulatory T cell therapy to the clinic
11:00-11:20
Dr Emma Hamilton-Williams, The University of Queensland Diamantina Institute - Antigen-specific immunotherapy for type 1 diabetes
11:20-11:35
Dr Anne-Sophie Bergot, The University of Queensland Diamantina Institute - Regulatory T cells induced following single antigen immunotherapy suppress islet-specific T cell responses to multiple antigens and protect from autoimmune diabetes
11:35-11:50
Pascale Wehr, The University of Queensland Diamantina Institute - Arthritogenic clonally-expanded autoantigen-specific CD4+ T cells are a target for prevention of autoimmune arthritis
11:50-12:05
Aimee Hanson, The University of Queensland Diamantina Institute - T-cell receptor immunosequencing reveals disease-associated clonal expansions and altered repertoire diversity in ankylosing spondylitis patients
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Dr Tobias Bald
13:15-13:45
Professor Matthew Krummel, Department of Pathology, University of California San Francisco (UCSF) - Disseminating Tumor-Self via A Synaptic Cellular ‘Mancala`
13:45-14:05
Associate Professor Thomas Gebhardt, Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity - Tissue-resident memory T cells promote melanoma-immune equilibrium in skin
14:05-14:20
Dr Ailin Lepletier, QIMR Berghofer Medical Research Institute - Tumor-intrinsic CD155 expression limits sensitivity to anti-PD-1 therapy in advanced metastatic melanoma
14:20-14:35
Diana Canals-Hernaez, The Biomedical Research Centre, University of British Columbia, Canada - Podocalyxin is a therapeutic target in carcinoma
14:35-14:50
Alvaro Sanchez-Herrero, Institute of Health & Biomedical Innovation, Queensland University of Technology - Tissue engineering of an orthotopic humanised bone-organ as a platform for preclinical multiple myeloma research
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Associate Professor Corey Smith and Dr Ashleigh Poh
15:30-16:00
Dr Emily Blyth, Westmead Clinical School, The Westmead Institute for Medical Research and Westmead Hospital - BMT Cell Therapies, Sydney - The way forward for antigen-specific T cells for immune reconstitution – stem cell donors or third party cell banks?
16:00-16:20
Dr Paulo Martins, Tumour Immunology Group, QIMR Berghofer Medical Research Institute - Serotherapy prevents cytomegalovirus reactivation after transplantation
16:20-16:35
Associate Professor Corey Smith, QIMR Berghofer Medical Research Institute - Restructuring of the TRBV landscape is coincident with clinical response to T cell therapy in transplant recipients
16:35-16:50
Simone Minnie, QIMR Berghofer Medical Research Institute - Stem cell transplantation establishes T cell-dependent myeloma immune-equilibrium that can be enhanced with immunotherapy
16:50-17:05
Dr Matthias Braun, QIMR Berghofer Medical Research Institute - Loss of DNAM-1 on CD8+ T cells: a novel immune escape mechanism
Location: Boulevard Auditorium Foyer
Join us for welcome refreshments and the first poster session.
Location: Boulevard Auditorium
Sponsored by Icon Group Australia
Join us for a public forum open to conference delegates and members of the general public to attend. This is a free session.
For more details and to register, visit the event website.
FRIDAY - 24th May 2019
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Professor Mark Smyth
Professor Matthew Krummel, Department of Pathology, University of California San Francisco (UCSF) - Imaging a World Beyond Checkpoint: Archetypes of Immunity in Tumors and Beyond
Location: Boulevard Auditorium
Chair: Associate Professor Michele Teng
09:30-09:50
Associate Professor John Stagg, CRCHUM and Institute of Cancer, University of Montreal - Targeting CD73 in cancer immunotherapy: beyond adenosine inhibition
09:50-10:10
Dr Courtney Beers, Vice President, Immunology, Tizona Therapeutics, San Francisco - Targeting CD39 with a First-in-Class Inhibitory Antibody Prevents ATP Processing and Increases T-Cell Activation
10:10-10:30
Dr Pam Holland, Vice President, Cancer Biology, Surface Oncology, Cambridge - Targeting the Adenosine Axis to Treat Cancer
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Dr Nic Waddell
11:00-11:30
Dr Jinmiao Chen, Single-Cell Computational Immunology (SCCI), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore - Single-cell analysis of crosstalk between tumor, immune cells and pathogens in gastric cancer
11:30-11:45
Dr Ann-Marie Patch, Head of Clinical Genomics Group, QIMR Berghofer Medical Research Institute - Bridging the fields of cancer genomics and Immunotherapy
11:45-12:00
Dr Andreas Behren, Olivia Newton-John Cancer Research Institute - The immunopeptidome of melanoma
12:00-12:15
Dr Simon Junankar, Garvan Institute of Medical Research - DNA barcoding demonstrates immuno-editing of metastatic breast cancer cells at the clonal level
12:15-12:30
Dr Jessica Engel, QIMR Berghofer Medical Research Institute - Mapping the Development of Gut Pathogenic CD4+ T-cells during Graft-versus-Host Disease using single-cell RNA-seq
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Dr Tobias Bald
13:30-14:00
Dr Jan Böttcher, Institute of Molecular Immunology and Experimental Oncology, Technical University Munich - The role of cDC1/NK cell communication within the tumor microenvironment for anti-cancer immunity
14:00-14:20
Dr Tatyana Chtanova, Innate and Tumour Immunology, Garvan Institute of Medical Research - Innate immune cells in cancer: Teaching neutrophils new tricks
14:20-14:35
Juming Yan, QIMR Berghofer Medical Research Institute - Title TBC
14:35-14:50
Associate Professor Eynav Klechevsky, Washington University School of Medicine, St. Louis - Upstream activation of anti-tumor immunity via human dendritic cell subsets
14:50-15:05
Amanda Oliver, Peter MacCallum Cancer Centre - Tissue-specific differences in the tumour microenvironment and their influence on immunotherapeutic response
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Associate Professor Antiopi Varelias
15:30-16:00
Dr Beth Helmink, Department of Surgical Oncology and Genomic Medicine, University of Texas MD Anderson Cancer Centre - Bringing concepts to clinic: the gut microbiome and the response to and toxicity of immune checkpoint blockade in melanoma
16:00-16:20
Professor Emad El-Omar, Director, Microbiome Research Centre, St George and Sutherland Clinical School, University of New South Wales - The role of the microbiome in GI cancer
16:20-16:40
Dr Nadeem Kaakoush, Head of Host-Microbiome Interactions Group, School of Medical Sciences, University of New South Wales, Sydney - Microbiome manipulation through faecal microbiota transplantation therapy
Location: Boulevard Auditorium
Chair: Dr Janin Chandra
18:40-17:10
Professor Man-Wah Tan, Infectious Diseases Therapeutic Area, Genentech, San Francisco, California - Harnessing nature’s gift: antibody and antibody-antibiotic conjugates to treat bacterial infections
17:10-17:30
Dr Keith Chappell, School of Chemistry and Molecular Biosciences, Faculty of Science, The University of Queensland - Rapid response pipeline for stabilized subunit vaccines
17:30-17:50
Dr Christian Engwerda, QIMR Berghofer Medical Research Institute - Type I interferons suppress anti-parasitic immunity and can be targeted to improve treatment of malaria and visceral leishmaniasis.
17:50-18:05
Dr Manisha Pandey, Institute for Glycomics, Griffith University - Immunotherapy with antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA humanized mice
SATURDAY - 25th May 2019
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Dr Elizabeth Ahern
09:00-10:00
Professor Christian Blank, Department of Medical Oncology & Division of Immunology, Netherlands Cancer Institute– Antoni van Leeuwenhoek Hospital, Amsterdam - Neoadjuvant Immunotherapy – the pathway to personalized immunotherapy in melanoma and beyond
10:00-10:30
Associate Professor Michele Teng, Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute - Neoadjuvant immunotherapy and surgery – a window of opportunity for tumor-specific T cell memory differentiation
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Dr Siok Tey
11:00-11:30
Professor Stephen Gottschalk, Dept. of Bone Marrow Transplantation & Cellular Therapy, St. Jude Children’s Hospital - Engineering Lymphocytes for the Adoptive Immunotherapy of Solid Tumors
11:30-11:50
Professor Simon Barry, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide - Title TBC
11:50-12:05
Dr Blake Aftab, Preclinical and Translational Sciences, Atara Biotherapeutics - CD19 Chimeric Antigen Receptor (CAR) Engineered Epstein-Barr Virus (EBV) Specific T cells – An Off-the-Shelf, Allogeneic CAR T-Cell Immunotherapy Platform
12:05-12:20
Professor Riccardo Dolcetti, The University of Queensland Diamantina Institute - Enhancing CAR-T cell immunotherapy against solid tumours by exploiting nanoemulsion-based indirect vaccination
12:20-12:35
Jessica Michie, Peter MacCallum Cancer Centre - Antagonism of IAPs enhances CAR T cell efficacy
Location: Boulevard Auditorium Foyer
Location: Boulevard Auditorium
Chair: Dr Andrea Henden
14:00-14:20
Associate Professor Victoria Atkinson, School of Clinical Medicine, The University of Queensland and Medical Oncologist, Princess Alexandra and Greenslopes Private Hospitals, Brisbane - Modern Immunotherapy for advanced melanoma
14:20-14:40
Professor Sandro Porceddu, Director Radiation Oncology Research, Cancer Services, Princess Alexandra Hospital and Faculty of Medicine, University of Queensland - The evolution and role of immunotherapy in head and neck cancer
14:40-15:00
Professor Ken O’Byrne, Medical Oncologist, Princess Alexandra Hospital, Queensland University of Technology, Translational Research Institute - Title TBC
15:00-15:20
Dr Alistair Cook, Research Fellow, Faculty of Health and Medical Sciences, UWA Medical School, The University of Western Australia - Results of a phase 2 trial of DuRvalumab with first line chEmotherApy in Mesothelioma (DREAM)
Location: Boulevard Auditorium
Sponsorship
Interested to support this conference. Download our prospectus and become a sponsor today.
Register Now
Early Bird Registration ends Friday 22 March 2019! Save $150 on Standard registration fees.
2019 Sponsors and Supporters
Contact Us
E conferences@qimrberghofer.edu.au
T +61 7 3362 0397
QIMR Berghofer Medical Research Institute
Locked bag 2000
Royal Brisbane Hopsital QLD 4029
Sign up for Email updates
Receive information including deadline reminders, speaker profiles, program changes and much more...
©2018